L-theanine (L-theanine, L-The) is currently a highly valuable product in the fields of functional amino acids and biomanufacturing, possessing four major advantages: clear natural sources, well-defined physiological functions, mature synthetic pathways, and stable market demand. It is also a typical representative of fermentation methods replacing traditional extraction and chemical synthesis. Based on literature and industry data, this article systematically reviews L-theanine from five dimensions: source, physicochemical properties, biological functions, biosynthetic pathways, and market.

I. Source of L-theanine

L-theanine is a characteristic non-protein amino acid in tea plants, naturally occurring mainly in the root tips and new shoots of Theaceae plants (such as Camellia sinensis), accounting for 50%–60% of the total free amino acids in tea leaves. It is the core substance responsible for the umami flavor and calming effects of tea infusion. Apart from tea plants, it is only found in trace amounts in a few fungi, Camellia sasanqua, and oil tea, with a highly concentrated natural distribution. Traditional acquisition methods primarily rely on tea extraction, but the content in dry tea is only 0.1%–2%, with limited raw materials, high costs, and susceptibility to seasonal and regional influences, making it difficult to meet large-scale demand. Currently, industrial production has shifted to microbial biosynthesis, using Escherichia coli and Corynebacterium glutamicum as chassis cells and cheap carbon sources such as glucose as substrates, achieving green de novo synthesis independent of tea plants and without the addition of toxic ethylamine, representing the direction of industrial upgrading.

II. Physicochemical Properties of L-Theanine

L-Theanine, chemically named N-ethyl-γ-L-glutamine, has the molecular formula C7H14N2O3, a relative molecular mass of 174.2, and a molecular structure featuring a γ-glutamyl group and an ethylamine group, which determine its unique physicochemical properties: Solubility: Easily soluble in water, slightly soluble in dilute ethanol, almost insoluble in organic solvents such as ether and acetone, with a neutral aqueous solution, facilitating its application in food and beverage formulations. Stability: Stable under acidic conditions, easily decomposes into glutamic acid and ethylamine under alkaline conditions; stable at room temperature and pressure, resistant to high temperatures and conventional processing conditions. Taste characteristics: It has a fresh, sweet, and mellow taste with a slight caramel aroma, can mask bitterness and astringency, and synergistically enhance umami, making it a natural flavor enhancer. Chirality: Natural products are all in the L-configuration, with biological activity far higher than the D-form, preferentially absorbed and utilized by the human body, and its safety has been certified by multiple authoritative countries. III. Biological Functions of L-Theanine L-Theanine has been proven to possess multiple functions such as neuromodulation, mood relaxation, cognitive enhancement, cardiovascular protection, and antioxidant effects, making it a core ingredient in the emotional health and brain health track: Stress relief and sleep improvement: One of the most significant functions of L-theanine is promoting relaxation without causing drowsiness. It promotes the generation of alpha waves in the brain, reducing anxiety; when combined with GABA (γ-aminobutyric acid), it can shorten sleep latency and increase the proportion of deep sleep without the risk of dependence. Cognitive and focus enhancement: It improves attention, reaction speed, and memory consolidation; when combined with caffeine, it can achieve “mental clarity” and is widely used in functional beverages. Neuroprotection: It crosses the blood-brain barrier, reduces oxidative stress and inflammatory damage, and has potential protective effects against neurodegenerative damage. Auxiliary blood pressure regulation: It inhibits angiotensin-converting enzyme, gently regulates blood pressure, and is friendly to people with hypertension. Antioxidant and immune regulation: It enhances the activity of antioxidant enzymes in the body, reduces the levels of inflammatory factors, and synergistically with cysteine can enhance immune response and promote postoperative recovery. Based on the above functions, L-theanine has been classified as a GRAS (Generally Recognized as Safe) substance by the U.S. FDA. In 2014, China included tea theanine as a new food ingredient, and in 2025, L-theanine (fermentation method) entered the new food ingredient public list, with its application boundaries continuously expanding.

IV. L-Theanine Biosynthesis Pathways

The core of L-theanine biosynthesis is glutamate + ethylamine → L-theanine. Currently, three major technical systems have been developed: natural plant pathway, enzymatic catalysis pathway, and microbial de novo synthesis pathway, among which microbial metabolic engineering de novo synthesis is the mainstream for industrialization. (I) Natural Plant Synthesis Pathway (in tea plants) The root tips of tea plants are the main synthesis site, completed in two steps: Precursor generation: Glutamate is generated from α-ketoglutarate via glutamate dehydrogenase (GDH) or the GS/GOGAT cycle; ethylamine is produced by decarboxylation of alanine via alanine decarboxylase (alaDC). Condensation: Theanine synthetase (TS) uses ATP as an energy source to catalyze the condensation of L-glutamate and ethylamine to form L-theanine, which is then transported to leaves for storage. Limitations: Low yield and long cycle in plants, not feasible for industrialization. (II) Enzymatic Catalysis Synthesis Pathway (in vitro/whole cell) The core enzymes are γ-glutamylmethylamine synthetase (GMAS) and γ-glutamyl transpeptidase (GGT): 1. ATP-dependent (GMAS) Substrates: L-glutamate + ethylamine + ATP Catalysis: GMAS specifically links the γ-glutamyl group to ethylamine, stereospecifically producing L-theanine with few byproducts and high purity. Bottleneck: Requires exogenous ATP, high cost; ethylamine is toxic, volatile, and inhibits cell growth. 2. Non-ATP-dependent (GGT) Substrates: L-glutamine + ethylamine Catalysis: GGT transfers the γ-glutamyl group via transpeptidation, no ATP required, low cost; but suffers from hydrolysis side reactions, resulting in low conversion rate. The advantage of enzymatic methods is fast reaction, but they still require precursor addition and do not achieve complete de novo synthesis. (III) Microbial Metabolic Engineering De Novo Synthesis Pathway (core industrialization pathway) Using E. coli K12 W3110 as the chassis and glucose as the sole carbon source, endogenous synthesis of ethylamine and glutamate directly produces L-theanine through fermentation, representing the current highest technical level. 1. Core Synthesis Module Design • Ethylamine synthesis module: Acetaldehyde → (ω-transaminase, spuC) → ethylamine Acetaldehyde is provided from pyruvate via aldehyde dehydrogenase (eutE); the transaminase uses alanine as the amino donor to convert acetaldehyde to ethylamine, avoiding excessive accumulation of ethylamine that is toxic to cells from the alanine decarboxylation pathway. • Theanine production module: L-glutamate + ethylamine + ATP → (GMAS) → L-theanine GMAS from Paracoccus denitrificans and Methylophilus methylotrophus is used, with high catalytic efficiency and specificity. • Energy regeneration module: Polyphosphate kinase (ppk) catalyzes polyphosphate to regenerate ATP, solving the energy bottleneck of GMAS and reducing costs. 2. Metabolic Engineering Strategies 1. Enhance key enzyme copy numbers: Integrate double copies of gmas and single/double copies of spuC into the genome to balance synthesis rates and avoid insufficient or excessive ethylamine. 2. Enhance precursor supply: Ethylamine precursor: Overexpress eutE to increase acetaldehyde supply; Glutamate precursor: Overexpress ppc to strengthen TCA carbon flux, knock out sucCD to reduce α-ketoglutarate loss, integrate gdh to enhance glutamate synthesis; Alanine replenishment: Introduce alD from Bacillus subtilis to recycle pyruvate → alanine, continuously supplying the transaminase substrate. 3. Block bypass metabolism: Knock out ldhA (lactate dehydrogenase) and pflB (pyruvate formate lyase) to reduce pyruvate flow to lactate and formate, improving carbon utilization. 4. Optimize energy system: Overexpress ppk to construct an ATP regeneration system, significantly increasing intracellular ATP levels and improving per-cell yield.3. Typical engineered strain and fermentation indicators: Recombinant strain Tea11 in a 5 L fermenter without ethylamine addition: Fermentation time: 28 h; Yield: 22.60 g/L; Sugar-to-acid conversion rate: 41.71%; Advantages: Endogenous control of ethylamine, low cytotoxicity, and superior sugar-to-acid conversion rate compared to similar de novo synthesis pathways. After optimization with exogenous ethylamine supplementation, the yield reached 31.67 g/L with a sugar-to-acid conversion rate of 45.62%, balancing efficiency and safety. Professor Chen Ning’s team at Tianjin University of Science and Technology performed gene editing on wild-type Escherichia coli. After optimizing fermentation conditions, the recombinant strain produced 70.6 g/L of theanine in a 5 L bioreactor.

V. L-Theanine Market Analysis

L-Theanine is an essential ingredient in three major tracks: emotional health, functional foods, and brain health. The market size is growing steadily, with technological iterations driving cost reduction and penetration rate improvement.

1. Global and Domestic Market Size

Global market: approximately $64 million in 2026, expected to reach $120 million by 2035, with a CAGR of 6.6%. Health products account for 44%, and medical applications about 23%.

Domestic market: approximately 680 million RMB in 2025, with a CAGR of 20.7% from 2021 to 2025; expected to exceed 1.4 billion RMB by 2030, maintaining high growth of over 15%.

Production capacity: China is the world’s largest producer, accounting for 77.89% of global output. Leading companies have a combined capacity of over 800 tons/year, with the proportion of high-purity products (≥98%) continuously increasing.

1. Downstream Application Structure

Functional foods (about 48%): functional beverages, gummies, meal replacements, baked goods, focusing on “calming, sleep aid, concentration” as the largest application scenario.

Dietary supplements (about 32%): tablets, capsules, oral liquids for mood management and nerve health, often combined with GABA, melatonin, caffeine, etc.

Pharmaceuticals and daily chemicals (about 20%): pharmaceutical intermediates, antioxidant skincare, soothing masks, with stable growth in demand.

Emerging scenarios: pet emotional soothing supplements, with fast growth and great potential.

1. Core Driving Factors

Policy dividends: fermentation-derived L-theanine has been included in the new food ingredient list, removing raw material restrictions and opening up food application space.

Consumption upgrade: anxiety and sleep issues are becoming younger, with a surge in demand for “emotional value” and high repurchase rates for stress-relief and sleep-aid products.

Technological breakthroughs: microbial de novo synthesis replaces extraction and chemical methods, reducing costs, improving purity, and ensuring green compliance.

Formula innovation: combined with caffeine, GABA, vitamins, etc., covering more scenarios and rapidly increasing penetration.

VI. Summary

L-Theanine is a high-quality target in biosynthetic selection with high maturity, rigid demand, and certain growth: clear natural source, defined function, and complete compliance; the microbial de novo synthesis pathway has achieved one-step fermentation from glucose to theanine, with moderate technical barriers and easy scale-up; the market is in a stable growth period with diverse downstream applications, combining multiple values of food, health products, and medicine. With the official approval of fermentation methods and continuous optimization of metabolic engineering, L-theanine will further replace traditional processes and become a benchmark product for functional amino acid biomanufacturing.

generalsteel.cheng

See Full Bio